Wells Fargo
PAVM icon

Wells Fargo’s PAVmed PAVM Stock Holding History

Wells Fargo’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$457 Sell
45
-10
-18% -$95 ﹤0.01% 6405
2025
Q4 		$363 Hold
55
– – ﹤0.01% 6356
2025
Q3 		$709 Buy
55
+7
+15% +$104 ﹤0.01% 6275
2025
Q2 		$867 Hold
48
– – ﹤0.01% 6324
2025
Q1 		$1.04K Sell
48
-30
-38% -$622 ﹤0.01% 6237
2024
Q4 		$1.48K Sell
78
-15
-16% -$443 ﹤0.01% 6221
2024
Q3 		$3.42K Sell
93
-37
-28% -$1.14K ﹤0.01% 5987
2024
Q2 		$3.18K Sell
130
-108
-45% -$5.38K ﹤0.01% 5945
2024
Q1 		$15.3K Sell
238
-143
-38% -$10.8K ﹤0.01% 5645
2023
Q4 		$47K Sell
381
-289
-43% -$34.1K ﹤0.01% 5299
2023
Q3 		$88.9K Sell
670
-105
-14% -$16.3K ﹤0.01% 4844
2023
Q2 		$142K Hold
775
– – ﹤0.01% 4793
2023
Q1 		$130K Sell
775
-40
-5% -$8.42K ﹤0.01% 4686
2022
Q4 		$176K Buy
815
+128
+19% +$48.3K ﹤0.01% 4243
2022
Q3 		$265K Buy
687
+372
+118% +$211K ﹤0.01% 4083
2022
Q2 		$132K Sell
315
-129
-29% -$62.3K ﹤0.01% 4486
2022
Q1 		$264K Buy
444
+88
+25% +$65.4K ﹤0.01% 4826
2021
Q4 		$394K Sell
356
-43
-11% -$93.5K ﹤0.01% 4855
2021
Q3 		$1.53M Sell
399
-12
-3% -$37.8K ﹤0.01% 3892
2021
Q2 		$1.18M Sell
411
-129
-24% -$305K ﹤0.01% 4096
2021
Q1 		$1.08M Buy
540
+50
+10% +$75.2K ﹤0.01% 4192
2020
Q4 		$468K Buy
490
+198
+68% +$169K ﹤0.01% 4567
2020
Q3 		$234K Buy
292
+176
+152% +$157K ﹤0.01% 4877
2020
Q2 		$110K Buy
+116
New +$116K ﹤0.01% 5185
2020
Q1 		– Hold
0
– – – 6628

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo's PAVM Position: Q1 2026 in Review

Wells Fargo reduced its PAVmed (PAVM) stake by 18% in Q1 2026, selling an estimated $95 and leaving 45 shares worth $457. The position accounts for ﹤0.01% of the portfolio, ranked #6405.

Wells Fargo first reported a position in PAVM in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.53M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Wells Fargo held 45 shares of PAVmed worth $457 as of Q1 2026.
  • Wells Fargo sold 10 PAVmed shares in Q1 2026, an estimated $95.
  • PAVmed made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6405 holding.
  • Wells Fargo first reported a position in PAVmed in Q2 2020 and has held it in 24 quarters since.
  • Wells Fargo's PAVmed position peaked at $1.53M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.